HK1 and breast cancer: Tumor-derived EVs secreted by highly metastatic breast cancer cells could load miR-122 to increase nutrient availability in lung metastatic cancer cells by down-regulating the glycolytic enzyme pyruvate kinase in lung fibroblasts, as a result, facilitating the formation and development of breast cancer lung metastasis (57).